Clinical Radiology
Volume 65, Issue 9 , Pages 677-684, September 2010

Cardiac drugs used in cross-sectional cardiac imaging: what the radiologist needs to know

  • P. McParland

      Affiliations

    • Department of Cardiothoracic Radiology, Southampton University Hospitals NHS Trust, Southampton, UK
  • ,
  • E.D. Nicol

      Affiliations

    • Department of Radiology, Royal Brompton Hospital, London, UK
    • Department of Cardiology, Royal Brompton Hospital, London, UK
    • Department of Cardiology, Royal Berkshire Hospital, Reading, UK
  • ,
  • S.P. Harden

      Affiliations

    • Department of Cardiothoracic Radiology, Southampton University Hospitals NHS Trust, Southampton, UK
    • Corresponding Author InformationGuarantor and correspondent: S. P. Harden, Department of Cardiothoracic Radiology, Southampton University Hospitals NHS Trust, Southampton, UK. Tel.: +44 (0) 2380 794833; fax: +44 (0) 2380 796341.

Received 25 January 2010; received in revised form 28 March 2010; accepted 6 April 2010. published online 01 June 2010.

The demand for cross-sectional imaging of the heart is increasing dramatically and in many centres these imaging techniques are being performed by radiologists. Although radiologists are familiar with the computed tomography (CT) and magnetic resonance imaging (MRI) techniques to generate high-quality images and with using contrast agents, many are less familiar with administering the drugs necessary to perform CT coronary angiography and cardiac MR reliably. The aim of this article is to give an overview of the indications for and the contraindications to administering cardiac drugs in cross-sectional imaging departments. We also outline the complications that may be encountered and provide advice on how to treat these complications when they occur.

 

PII: S0009-9260(10)00151-0

doi:10.1016/j.crad.2010.04.002

Clinical Radiology
Volume 65, Issue 9 , Pages 677-684, September 2010